Paradigm Biopharmaceuticals Limited
PAR.AXParadigm Biopharmaceuticals Limited in brief
Paradigm Biopharmaceuticals Limited is a listed company in the Biotechnology industry, based in Australia. Its last known market value was $107 M (January 2024); there is no current figure. Its shares trade under the symbol PAR.AX (ASX).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Paradigm Biopharmaceuticals Limited timeline
- 2015
- 🔔Initial public offering on Australian Securities Exchange as PAR
Events of Paradigm Biopharmaceuticals Limited from Wikidata. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in Australia: #256 (Jan 2020) · #266 (Jan 2021) · #383 (Jan 2022) · #335 (Dec 2022) · #400 (Jul 2023) · #484 (Jan 2024)
Mutual funds holding Paradigm Biopharmaceuticals Limited#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Dimensional International Small Cap ETFDimensional Fund Advisors LP | 54,522 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 1 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Paradigm Biopharmaceuticals Limited🇦🇺 | $107 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Profile updated:
- Nov 4, 2026
Figures from value.today research, Wikidata.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Paradigm Biopharmaceuticals Limited? Verify and update this profile — free
Show Paradigm Biopharmaceuticals Limited's ranking on your website Get the badge
The badge updates itself as the ranking changes.